SAVE THE DATE
Saturday, April 7, 2018
2:00 p.m. EDT
Watch this page to learn how you can register to join this meeting.
What can you do to REST-ON?
Join us for an informational webcast to learn about Flamel’s REST-ON Phase III clinical study of once-nightly sodium oxybate (FT 218)
Our agenda features a panel of experts on FT 218, narcolepsy, sleep research, and leaders from patient advocacy groups
- Dr. Thomas Roth, PhD, Director of Sleep Disorders & Research Center, Henry Ford
- Dr. David Monteith, VP, Research & Development, Avadel Pharmaceuticals (Flamel)
- Julie Flygare, Founder, Project Sleep
- Dr. Eveline Honig, Executive Director, Narcolepsy Network
Follow us on Twitter: @AvadelPharma